|
Coagulation inhibitors
Citations 21-30 of 44 total displayed.
|
Past content
(since Apr 2001):
|
- Articles
Effect of Clopidogrel Premedication in Off-Pump Cardiac Surgery. Are We Forfeiting the Benefits of Reduced Hemorrhagic Sequelae?
- Emmanouil I. Kapetanakis, Diego A. Medlam, Kathleen R. Petro, Elizabeth Haile, Peter C. Hill, Mercedes K.C. Dullum, Ammar S. Bafi, Steven W. Boyce, and Paul J. Corso
Circulation published March 27, 2006, doi:10.1161/CIRCULATIONAHA.105.571828
[Abstract]
- Editorials
Direct Comparison of the A to Z and PROVE IT Trials: A Second Chance to Gain a First Impression
- B. Greg Brown
Circulation 2006;113:1382-1384, doi:10.1161/CIRCULATIONAHA.106.612374
[Full text]
- Basic Science for Clinicians
Molecular Regulation of Platelet-Dependent Thrombosis
- Jane E. Freedman
Circulation 2005;112:2725-2734, doi:10.1161/CIRCULATIONAHA.104.494468
[Abstract]
[Full text]
- Surgery for Coronary Artery Disease
Aprotinin Decreases Postoperative Bleeding and Number of Transfusions in Patients on Clopidogrel Undergoing Coronary Artery Bypass Graft Surgery: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
- Jan van der Linden, Gabriella Lindvall, and Ulrik Sartipy
Circulation 2005;112:I-276-280I-, doi:10.1161/CIRCULATIONAHA.104.524611
[Abstract]
[Full text]
- Editorials
Diabetes, Coronary Intervention, and Platelet Glycoprotein IIb/IIIa Blockade: The Triad Revisited
- W.H. Wilson Tang and A. Michael Lincoff
Circulation 2004;110:3618-3620, doi:10.1161/01.CIR.0000151355.07568.B4
[Full text]
- Review: Current Perspective
Bidirectional Relation Between Inflammation and Coagulation
- Marcel Levi, Tom van der Poll, and Harry R. Büller
Circulation 2004;109:2698-2704, doi:10.1161/01.CIR.0000131660.51520.9A
[Full text]
- Focused Perspectives
Are Stenting and Glycoprotein IIb/IIIa Blockade of Good Value in Primary Percutaneous Coronary Intervention?
- Jason H. Cole and William S. Weintraub
Circulation 2003;108:2831-2833, doi:10.1161/01.CIR.0000106681.88891.F2
[Full text]
- Correspondence
Clopidogrel in Acute Coronary Syndromes: Can the Cost Effectiveness Improve? • Response
- Enrique Sánchez-Delgado, Salim Yusuf, Shamir R. Mehta, Feng Zhao, Bernard J. Gersh, Patrick J. Commerford, Mel Blumenthal, Andrzej Budaj, Thomas Wittlinger, and Keith A.A. Fox
Circulation 2003;108:e56, doi:10.1161/01.CIR.0000086778.57755.6A
[Full text]
- Cardiology Patient Pages
Antiplatelet Therapy
- Robert A. Harrington, Patricia K. Hodgson, and Rhonda L. Larsen
Circulation 2003;108:e45-47e, doi:10.1161/01.CIR.0000083142.13956.D6
[Full text]
- Basic Science Reports
Glycosyl Phosphatidylinositol Anchorage of Tissue Factor Pathway Inhibitor
- Jing Zhang, Orlando Piro, Lan Lu, and George J. Broze, Jr
Circulation 2003;108:623-627; published online before print as doi:10.1161/01.CIR.0000078642.45127.7B
[Abstract]
[Full text]
|
|
